Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST expert opinion meeting

Daniele Prati, Daniele Prati, Antonio Gasbarrini, Francesco Mazzotta, Evangelista Sagnelli, Giampiero Carosi, Nicola Abrescia, Alfredo Alberti, Silvia Ambu, Piero Andreone, Angelo Andriulli, Mario Angelico, Giorgio Antonucci, Antonio Ascione, Luca Saverio Belli, Raffaele Bruno, Savino Bruno, Patrizia Burra, Calogero Cammà, Nicola CaporasoGiuseppe Cariti, Umberto Cillo, Nicola Coppola, Antonio Craxì, Andrea De Luca, Eleonora De Martin, Vito Di Marco, Stefano Fagiuoli, Carlo Ferrari, Giovanni Battista Gaeta, Massimo Galli, Antonio Grieco, Paolo Grossi, Anna Licata, Ivana Maida, Alessandra Mangia, Nicoletta Marino, Renato Maserati, Gabriele Missale, Mario Mondelli, Paola Nasta, Grazia Niro, Marcello Persico, Enzo Petrelli, Antonio Picciotto, Fabio Piscaglia, Teresa Pollicino, Daniele Prati, Claudio Puoti, Massimo Puoti, Giovanni Raimondo, Maria Grazia Rumi, Evangelista Sagnelli, Teresa Santantonio, Antonina Smedile, Giovanni Squadrito, Gianluca Svegliati Baroni, Gloria Taliani, Marcello Tavio, Mario Toti, Ferruccio Bonino, Maurizia Rossana Brunetto, Bruno Cacopardo, Marcello Caremani, Roberto Cauda, Massimo Colombo, Giovanni Di Perri, Francesca Donato, Patrizia Farci, Giovanna Fattovich, Gaetano Filice, Florio Ghinelli, Vincenzo Guadagnino, Adriano Lazzarin, Massimo Levrero, Giuseppe Licata, Anna Orani, Amerigo Paffetti, Giuseppe Pastore, Felice Piccinino, Eligio Pizzigallo, Patrizia Pontisso, Vincenzo Portelli, Mario Rizzetto, Alessandro Rossi, Tommaso Stroffolini, Enzo Ubaldi, Daniele Prati, Antonio Gasbarrini, Teresa Santantanio, Alfredo Alberti, Maria Grazia Rumi, Savino Bruno, Stefano Fagiuoli, Paolo Grossi, Raffaele Bruno, Giovanni Battista Gaeta, Giorgio Francesco Antonucci, Claudio Puoti, Calogero Cammà, Antonio Craxì

Research output: Contribution to journalArticle

Abstract

It is increasingly clear that a tailored therapeutic approach to patients with hepatitis C virus infection is needed. Success rates in difficult to treat and low-responsive hepatitis C virus patients are not completely satisfactory, and there is the need to optimise treatment duration and intensity in patients with the highest likelihood of response. In addition, the management of special patient categories originally excluded from phase III registration trials needs to be critically re-evaluated. This article reports the recommendations for the treatment of hepatitis C virus infection on an individual basis, drafted by experts of three scientific societies.

Original languageEnglish
Pages (from-to)81-91
Number of pages11
JournalDigestive and Liver Disease
Volume42
Issue number2
DOIs
Publication statusPublished - Feb 2010

    Fingerprint

Keywords

  • Acute hepatitis
  • Antiviral therapy
  • Chronic hepatitis
  • Cirrhosis
  • Elderly patients
  • HBV
  • HCV
  • HDV
  • HIV
  • Liver transplantation

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Prati, D., Prati, D., Gasbarrini, A., Mazzotta, F., Sagnelli, E., Carosi, G., Abrescia, N., Alberti, A., Ambu, S., Andreone, P., Andriulli, A., Angelico, M., Antonucci, G., Ascione, A., Belli, L. S., Bruno, R., Bruno, S., Burra, P., Cammà, C., ... Craxì, A. (2010). Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST expert opinion meeting. Digestive and Liver Disease, 42(2), 81-91. https://doi.org/10.1016/j.dld.2009.08.001